↓ Skip to main content

BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease

Overview of attention for article published in Neurobiology of Aging, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
patent
11 patents

Citations

dimensions_citation
111 Dimensions

Readers on

mendeley
196 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
Published in
Neurobiology of Aging, June 2013
DOI 10.1016/j.neurobiolaging.2013.05.006
Pubmed ID
Authors

Yen Ying Lim, Victor L. Villemagne, Simon M. Laws, David Ames, Robert H. Pietrzak, Kathryn A. Ellis, Karra D. Harrington, Pierrick Bourgeat, Olivier Salvado, David Darby, Peter J. Snyder, Ashley I. Bush, Ralph N. Martins, Colin L. Masters, Christopher C. Rowe, Pradeep J. Nathan, Paul Maruff, Biomarkers and Lifestyle Research Group Australian Imaging

Abstract

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism has previously been implicated in Alzheimer's disease (AD)-related cognitive impairment. We aimed to determine the relationship between BDNF Val66Met and beta-amyloid (Aβ) on cognitive decline, hippocampal atrophy, and Aβ accumulation over 36 months in 165 healthy adults enrolled in the Australian Imaging, Biomarkers and Lifestyle study. In healthy adults with high Aβ, Met carriers showed significant and moderate-to-large declines in episodic memory, executive function, and language, and greater hippocampal atrophy over 36 months, compared with Val/Val homozygotes. BDNF Val66Met was not found to be related to rates of change in cognition or hippocampal volume in healthy adults with low Aβ. BDNF Val66Met did not relate to the amount of Aβ or to the rate of Aβ accumulation in either group. High Aβ levels coupled with Met carriage may be useful prognostic markers of accelerated cognitive decline and hippocampal degeneration in individuals in the preclinical stage of AD.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 196 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Germany 1 <1%
Canada 1 <1%
Israel 1 <1%
Greece 1 <1%
Argentina 1 <1%
Unknown 189 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 37 19%
Researcher 30 15%
Student > Bachelor 24 12%
Student > Master 16 8%
Student > Doctoral Student 15 8%
Other 46 23%
Unknown 28 14%
Readers by discipline Count As %
Medicine and Dentistry 36 18%
Neuroscience 33 17%
Psychology 31 16%
Agricultural and Biological Sciences 15 8%
Biochemistry, Genetics and Molecular Biology 8 4%
Other 32 16%
Unknown 41 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#1,964,496
of 25,373,627 outputs
Outputs from Neurobiology of Aging
#341
of 4,418 outputs
Outputs of similar age
#16,521
of 209,791 outputs
Outputs of similar age from Neurobiology of Aging
#7
of 41 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,418 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,791 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.